Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aventis's new vector complexes useful in gene therapy of cancer

March 5, 2001

Faulding to market and sell NaPro's paclitaxel in Europe

March 5, 2001

Introgen's INGN-241 shows antitumor activity against human melanoma

March 5, 2001

Arglabin-DMA acts as an inhibitor of posttranslational processing of Ras protein

March 5, 2001

Millennium begins phase II clinical trial of LDP-341 for treatment of multiple myeloma

March 5, 2001

Regulatory submissions filed for novel STI targeting abnormal protein in CML

March 2, 2001

Antineoplastic coumarone analogues identified at Sankyo

March 2, 2001

DepoCyt again available in the U.S. for lymphomatous meningitis

March 2, 2001

Herzyme IND filed in Canada; Ribozyme anticipates initiation of phase I trials in Vancouver

March 2, 2001

Genta begins new phase III with Genasense for treatment of CLL

March 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...